Orexin Receptor 2 Agonist Improves Sleepiness in Narcolepsy

For patients with narcolepsy type 1, TAK-994 improves measures of sleepiness and cataplexy over 8 weeks compared with placebo.

Related Keywords

France , Yves Dauvilliers , University Of Montpellier , Takeda Development Center Americas , Healthday News , New England Journal , Gui De Chauliac Hospital , Wakefulness Test , Epworth Sleepiness Scale , Takeda Development Center ,